Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Quantifying variability of intrafractional target motion in stereotactic body radiotherapy for lung cancers.

Chan MK, Kwong DL, Tam E, Tong A, Ng SC.

J Appl Clin Med Phys. 2013 Sep 6;14(5):140-52. doi: 10.1120/jacmp.v14i5.4319.

PMID:
24036866
2.

Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.

Shimohigashi Y, Toya R, Saito T, Ikeda O, Maruyama M, Yonemura K, Nakaguchi Y, Kai Y, Yamashita Y, Oya N, Araki F.

Radiat Oncol. 2017 Mar 23;12(1):61. doi: 10.1186/s13014-017-0799-7.

3.

Accuracy and sensitivity of four-dimensional dose calculation to systematic motion variability in stereotatic body radiotherapy (SBRT) for lung cancer.

Chan MK, Kwong DL, Ng SC, Tong AS, Tam EK.

J Appl Clin Med Phys. 2012 Nov 8;13(6):3992. doi: 10.1120/jacmp.v13i6.3992.

PMID:
23149792
4.

Intrafractional Baseline Shift or Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System.

Takao S, Miyamoto N, Matsuura T, Onimaru R, Katoh N, Inoue T, Sutherland KL, Suzuki R, Shirato H, Shimizu S.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):172-80. doi: 10.1016/j.ijrobp.2015.09.024. Epub 2015 Sep 25.

PMID:
26700711
5.

Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.

Takahashi W, Yamashita H, Kida S, Masutani Y, Sakumi A, Ohtomo K, Nakagawa K, Haga A.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):426-31. doi: 10.1016/j.ijrobp.2013.02.019. Epub 2013 Apr 5.

PMID:
23562767
6.

Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy.

Richter A, Wilbert J, Baier K, Flentje M, Guckenberger M.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):618-27. doi: 10.1016/j.ijrobp.2009.11.028. Epub 2010 May 6.

PMID:
20452143
7.

Planning 4-dimensional computed tomography (4DCT) cannot adequately represent daily intrafractional motion of abdominal tumors.

Ge J, Santanam L, Noel C, Parikh PJ.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):999-1005. doi: 10.1016/j.ijrobp.2012.09.014. Epub 2012 Oct 23.

PMID:
23102840
8.

Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography.

Bissonnette JP, Franks KN, Purdie TG, Moseley DJ, Sonke JJ, Jaffray DA, Dawson LA, Bezjak A.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):688-95. doi: 10.1016/j.ijrobp.2008.11.066. Epub 2009 Apr 22.

PMID:
19395200
9.

Implementation of feedback-guided voluntary breath-hold gating for cone beam CT-based stereotactic body radiotherapy.

Peng Y, Vedam S, Chang JY, Gao S, Sadagopan R, Bues M, Balter P.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):909-17. doi: 10.1016/j.ijrobp.2010.08.011. Epub 2011 Apr 4.

PMID:
21470784
10.

Liver motion during cone beam computed tomography guided stereotactic body radiation therapy.

Park JC, Park SH, Kim JH, Yoon SM, Song SY, Liu Z, Song B, Kauweloa K, Webster MJ, Sandhu A, Mell LK, Jiang SB, Mundt AJ, Song WY.

Med Phys. 2012 Oct;39(10):6431-42. doi: 10.1118/1.4754658.

PMID:
23039678
11.

Evaluation of the motion of lung tumors during stereotactic body radiation therapy (SBRT) with four-dimensional computed tomography (4DCT) using real-time tumor-tracking radiotherapy system (RTRT).

Harada K, Katoh N, Suzuki R, Ito YM, Shimizu S, Onimaru R, Inoue T, Miyamoto N, Shirato H.

Phys Med. 2016 Feb;32(2):305-11. doi: 10.1016/j.ejmp.2015.10.093. Epub 2016 Mar 2.

12.

Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.

Sonke JJ, Rossi M, Wolthaus J, van Herk M, Damen E, Belderbos J.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):567-74. doi: 10.1016/j.ijrobp.2008.08.004. Epub 2008 Nov 27.

PMID:
19046825
13.

A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.

Li G, Cohen P, Xie H, Low D, Li D, Rimner A.

Phys Med Biol. 2012 Nov 21;57(22):7579-98. doi: 10.1088/0031-9155/57/22/7579. Epub 2012 Oct 26.

PMID:
23103415
14.

Stability of percutaneously implanted markers for lung stereotactic radiotherapy.

Persson GF, Josipovic M, von der Recke P, Aznar MC, Juhler-Nøttrup T, Munck af Rosenschöld P, Korreman S, Specht L.

J Appl Clin Med Phys. 2013 Sep 6;14(5):187-95. doi: 10.1120/jacmp.v14i5.4337.

PMID:
24036871
15.

Systematic evaluation of lung tumor motion using four-dimensional computed tomography.

Sarudis S, Karlsson Hauer A, Nyman J, Bäck A.

Acta Oncol. 2017 Apr;56(4):525-530. doi: 10.1080/0284186X.2016.1274049. Epub 2017 Jan 11.

PMID:
28075183
16.

Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.

Pokhrel D, Badkul R, Jiang H, Kumar P, Wang F.

J Appl Clin Med Phys. 2015 Jan 8;16(1):5058. doi: 10.1120/jacmp.v16i1.5058.

PMID:
25679161
17.

Factors influencing intrafractional target shifts in lung stereotactic body radiation therapy.

Liu HW, Khan R, Nugent Z, Krobutschek K, Dunscombe P, Lau H.

Pract Radiat Oncol. 2014 Jan-Feb;4(1):e45-51. doi: 10.1016/j.prro.2013.02.013. Epub 2013 Apr 9.

PMID:
24621431
18.

Four-dimensional computed tomography prediction of inter- and intrafractional upper gastrointestinal tumor motion during fractionated stereotactic body radiation therapy.

Lischalk JW, Kole TP, Anjum HM, Obayomi-Davies O, Rashid A, Unger K.

Pract Radiat Oncol. 2016 May-Jun;6(3):176-82. doi: 10.1016/j.prro.2015.10.006. Epub 2015 Oct 22.

PMID:
26746816
19.

Craniocaudal safety margin calculation based on interfractional changes in tumor motion in lung SBRT assessed with an EPID in cine mode.

Ueda Y, Miyazaki M, Nishiyama K, Suzuki O, Tsujii K, Miyagi K.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1064-9. doi: 10.1016/j.ijrobp.2011.07.043. Epub 2012 Jan 13.

PMID:
22245190
20.

Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer.

Valdes G, Robinson C, Lee P, Morel D, Low D, Iwamoto KS, Lamb JM.

Med Dosim. 2015 Spring;40(1):64-9. doi: 10.1016/j.meddos.2014.10.002. Epub 2014 Dec 24.

PMID:
25542785

Supplemental Content

Support Center